The Spanish company said the agreements with the two local partners will enable Bioiberica to compete in a complex and demanding market, while expanding its presence in the Asia-Pacific region.
Aska Animal Health Co – Bioiberica’s official distributor in Japan – will initially import the company’s Nucleoforce aquaculture and livestock feed target range.
Nucleoforce consists of free nucleotides and active precursors obtained from yeast extracts. The company claims that various studies have shown that these products help strengthen the immune and digestive systems of young animals that are undergoing rapid maturation of their immune and intestinal systems.
As part of the deal, Asuka will assist BioIberica in managing regulatory processes and local R&D trials. Shintoa Corporation oversees promotion and sales of ingredients. Longer term, the trio also have plans to introduce the Barcelona-based company’s Parbio series (a source of hydrolyzed protein) to the Japanese market. I’m here.
“Japan is one of the major markets for livestock and aquaculture feed ingredient sales in both Asia and the world.” Joan Bassa, Head of Bioiberica’s Heparin Science, Animal Nutrition and Phytosanitary Business Unit, said: “However, it is a complex market to trade in, so working with a local partner was very important.Aska and Shintoa have long established strong positions in Japan and have a deep knowledge of the Japanese regulatory environment. with strong commercial capabilities and is considered an important supplier of feed ingredients to the animal nutrition market. ”na
Expanding our footprint in the Korean market na
In February of this year, Bioiberica entered into a strategic partnership with Mill Tech Co Inc to start selling Palbio in South Korea.
Mill Tech, which works with all major feed suppliers in South Korea, had an existing relationship with Bioiberica regarding the distribution of nucleotide-based products in its Asian market.
According to the company, the Parbio series meets the stringent regulatory requirements of Asian countries for animal feed ingredients. The company had to meet strict export requirements.
“Approval was obtained at the end of 2019 after a lengthy approval process with local health authorities. However, 2020 was the “lost year” due to the pandemic, which delayed product launches and sales. ” Basat told the publication at the time.
South Korea is one of the most difficult markets to access due to regulatory barriers, he added. Bassa also emphasized how important collaboration is when it comes to bringing products to new markets. “Much work has been done by both Bioiberica and Mill Tech, and by health authorities in both countries, to successfully achieve approval for this range. ”na
According to the company, the Parbio range is designed to support gut health in young animals, improve digestion and feed intake, and increase productivity in pigs, poultry and fish. na
.
Comments
Post a Comment